Emergent BioSolutions Inc. — Director's Dealing 2021

Feb 12, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2021-02-09

Reporting Person: LINDAHL RICHARD S (EVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-09	Common Stock	A	2495	—	Acquired	34301	Direct
2021-02-09	Common Stock	F	2522	$123.45	Disposed	31779	Direct

Footnotes

F1: Consists of Performance Stock Units ("PSUs") previously granted on May 8, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 7,486 shares of common stock, which is in excess of the 4,991 shares previously reported on May 10, 2018.

F2: Represents shares of common stock withheld to pay taxes due upon vesting of the PSUs.